tgen Archives

TGen’s Von Hoff inducted into Joshua Lederberg Society

dan-von-hoff

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug Abraxane for advanced pancreatic cancer patients. The Lederberg Society is named for the late Dr. Joshua Lederberg, a Nobel Prize laureate and leader in bacterial… Read More →

The Voice of Development: Joyce Grossman, AAED

Joyce Grossman 1 © Lillian Reid

Joyce Grossman became executive director of AAED in 2011. She has a B.A. from the University of California-Davis and a M.P.A. from California State University, Sacramento. Prior to joining AAED, Grossman was a deputy director with the City of Phoenix. She helped in attracting the International Genomics Consortium/Translational Genomics Research Institute to Phoenix. AZRE caught… Read More →

TGen’s Zenhausern is named an NAI fellow

bioscience

Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of Inventors (NAI). Zenhausern, Ph.D., MBA, will be inducted into the NAI Fellows by Deputy U.S. Commissioner for Patents Andy Faile, from the U.S. Patent and… Read More →

TGen's Zenhausern is named an NAI fellow

bioscience

Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of Inventors (NAI). Zenhausern, Ph.D., MBA, will be inducted into the NAI Fellows by Deputy U.S. Commissioner for Patents Andy Faile, from the U.S. Patent and… Read More →

TGen-Barrow-PCH study brain injuries

brain

In an effort to lower medical costs, identify patients at risk for injury, and speed patient recovery, scientists will attempt to identify a molecular signal that indicates severity of brain-injury during a $4 million, five-year federal grant to Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center, Phoenix Children’s Hospital and the Translational Genomics… Read More →

TGen-led study finds link to Parkinson’s disease

stem.cell

The absence of a protein called SMG1 could be a contributing factor in the development of Parkinson’s disease and other related neurological disorders, according to a study led by the Translational Genomics Research Institute (TGen). The study screened 711 human kinases (key regulators of cellular functions) and 206 phosphatases (key regulators of metabolic processes) to… Read More →

Quayle elected to TGen Foundation Board

quayle

Former U.S. Vice President Dan Quayle, who served under President George H.W. Bush from 1989-93, was elected today to the Board of Directors of the TGen Foundation, the philanthropic arm of the non-profit Translational Genomics Research Institute (TGen). Vice President Quayle attended grade school and high school in Phoenix and Scottsdale and he and his… Read More →

17th U.S. Surgeon General joins TGen advisory panel

bioscience

The 17th Surgeon General of the United States and President of Canyon Ranch Institute Richard H. Carmona, M.D., M.P.H., FACS, today joined the Translational Genomics Research Institute (TGen) advisory committee on rare childhood disorders. Dr. Carmona’s role on the National Advisory Committee for TGen’s Center for Rare Childhood Disorders (the Center) will be to help… Read More →

TGen identifies genes linked to unhealthy liver function

stem.cell

A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function. This is believed to be the nation’s first large-scale genome-wide association study in overweight patients with diabetes. Results of the study, done in conjunction with the Geisinger Health System,… Read More →

TGen researchers uncover root of myeloma relapse

stem.cell

Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years. Working in collaboration with colleagues at Princess Margaret Hospital in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics… Read More →

TGen Foundation plans two major fundraising events

medical.research

The Translational Genomics Research Institute (TGen) Foundation plans two climate-appropriate fundraising events — “Shop for a Cause” while it’s still hot, and “stepNout” when it cools off this fall. Mark your calendars for TGen’s 8th annual stepNout Run/Walk/Dash set for Nov. 3 at Kiwanis Park, 6111 S. All-America Way, in Tempe. Nearly 1,000 participants are… Read More →

$20,000 APS grant funds TGen education initiative

StemCellSciCamp08_5619

A $20,000 grant from the APS Foundation will help the Translational Genomics Research Institute (TGen) expand its TGen2School initiative by providing science kits and instruction in Science, Technology, Engineering and Math (STEM) education. The kits and accompanying instruction for teachers are part of the TGen2School initiative at TGen’s Pathogen Genomics Division – TGen North –… Read More →

Scientific internship helps build Arizona’s biomedical workforce

Krauss Honored For Science

Arizona’s future leaders in biology and medicine graduated today from one of the nation’s premier scientific internship programs, sponsored by Helios Education Foundation and the Translational Genomics Research Institute (TGen). The 45 interns in the 2013 Helios Scholars at TGen summer internship program completed eight weeks of biomedical investigations and presented their findings at a… Read More →

TGen-TD2-Scottsdale Healthcare study benefits patients

134127959

The Side-Out Foundation’s breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit – meaning their disease was controlled… Read More →